Drug discovery requires two separate steps: checking whether a drug can bind to a harmful molecule or its receptor, and ...

Joullié Lecture was established in 1993 by Wyeth Research to help strengthen the relationship between academia and industry.

AstraZeneca has signed one of the largest licensing deals yet with a China-based drug company.

In other developments, a federal court rejected, for now, the EPA’s move to rescind drinking-water limits for 4 PFAS ...

From high-tech gear to PFAS-free waxes and precision ice making, materials and chemistry advances define the Milan Cortina games ...

Despite a plethora of rules regulating ammonium nitrate, the chemical has become the most common explosive used in terror ...

C&EN Reporter Delger Erdenesanaa discusses the trials and takeaways of the 30th annual United Nations climate summit ...

Industrial development of COFs is not as advanced, but companies involved with MOFs are keeping an eye on them. Ben Hernandez, the CEO of Numat Technologies, which has been developing MOFs for ...

The process of integrity is fully embedded in the chemistry enterprise—from the collection of data to its analysis and ...

The Swiss drug services firm Siegfried plans to acquire two small-molecule manufacturing sites in the US and one in Australia ...

Continuing to battle against a hostile market environment, Dow says it plans to cut 4,500 jobs—13% of its workforce—as part ...

The UK pharmaceutical giant AstraZeneca is doubling down on its commitment to the Chinese drugmaker CSPC Pharmaceutical Group ...